0001779735-22-000001.txt : 20220520 0001779735-22-000001.hdr.sgml : 20220520 20220520164010 ACCESSION NUMBER: 0001779735-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220520 DATE AS OF CHANGE: 20220520 EFFECTIVENESS DATE: 20220520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vascular Perfusion Solutions, Inc. CENTRAL INDEX KEY: 0001779735 IRS NUMBER: 813798785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-446500 FILM NUMBER: 22948256 BUSINESS ADDRESS: STREET 1: 503 AVENUE A, SUITE 1115 CITY: SAN ANTONIO STATE: TX ZIP: 78215 BUSINESS PHONE: 210-977-0191 MAIL ADDRESS: STREET 1: 503 AVENUE A, SUITE 1115 CITY: SAN ANTONIO STATE: TX ZIP: 78215 D 1 primary_doc.xml X0708 D LIVE 0001779735 Vascular Perfusion Solutions, Inc. 312 Pearl Parkway Building 5, Suite 5104 SAN ANTONIO TX TEXAS 78215 210-977-0191 DELAWARE None None Corporation true Tom DeBrooke 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Leon Bunegin 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Director Mark Muller 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Klaus Weiswurm 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Director Celia Jairala 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Director Paul Perry 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Biotechnology Decline to Disclose 06b false 2022-05-17 false true false 0 5000000 500000 4500000 false 1 0 0 0 A portion of the proceeds will be used to pay compensation to some of the Executive Officers named in response to item 3 above. false Vascular Perfusion Solutions, Inc. Mark Muller Mark Muller CEO 2022-05-20